ADVANCED METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)

Clinical trials for ADVANCED METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC) explained in plain language.

Never miss a new study

Get alerted when new ADVANCED METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC) trials appear

Sign up with your email to follow new studies for ADVANCED METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New radioactive injection targets Hard-to-Treat breast cancer

Disease control Recruiting now

This early-phase trial tests the safety of a new radioactive drug, 225Ac-TR2205, in 15 women with advanced triple-negative breast cancer that has spread. The study aims to see if the treatment is tolerable and to measure how radiation moves through the body. It is not a cure, but…

Matched conditions: ADVANCED METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)

Phase: EARLY_PHASE1 • Sponsor: Xiaorong Sun • Aim: Disease control

Last updated May 19, 2026 11:59 UTC

ADVANCED METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)

Get alerted when new ADVANCED METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC) trials appear

New radioactive injection targets Hard-to-Treat breast cancer